
簡(jiǎn)要描述:Mitiglinide calcium hydrate 207844-01-7Mitiglinide is a drug for the treatment of type 2 diabetes.
產(chǎn)品分類(lèi)
Product Category詳細(xì)介紹
| 品牌 | absin | CAS | 207844-01-7 |
|---|---|---|---|
| 分子式 | C38H52CaN2O8 | 純度 | 99% |
| 分子量 | 704.91 | 貨號(hào) | abs47027743 |
| 規(guī)格 | 100mg | 供貨周期 | 現(xiàn)貨 |
| 主要用途 | is a drug for the treatment of type 2 d | 應(yīng)用領(lǐng)域 | 化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 |
Mitiglinide calcium hydrate 207844-01-7
| 產(chǎn)品描述 | |
| 描述 | Mitiglinide is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic beta-cells. Mitiglinide belongs to the meglitinide class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda. |
| 純度 | 99% |
| 儲(chǔ)存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | 米ge列奈鈣;Mitiglinide calcium hydrate;S-21403 calcium hydrate |
| 外觀(guān) | 白色或類(lèi)白色粉末 |
| 可溶性/溶解性 | 10 mM in DMSO |
| 參考文獻(xiàn) | |
| 參考文獻(xiàn) |
|
| 研究領(lǐng)域 | |
| 研究領(lǐng)域 | Metabolism Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產(chǎn)品咨詢(xún)

微信掃一掃